Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Minuk

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Canadian Liver Journal|December 28, 2023
Comparison of different definitions of metabolic syndrome and their associations with non-alcoholic fatty liver disease: a retrospective studyCarmen Tse, Nicholas Lisanti, Micah Grubert Van Iderstine, et al.
Canadian Liver Journal|August 22, 2022
Circulating and inducible IL-32α in chronic hepatitis C virus infectionMark Collister, Julia Rempel, Jiaqi Yang, et al.
Hepatology (Baltimore, Md.)|September 22, 2005
Antioxidative function of L-FABP in L-FABP stably transfected Chang liver cellsGuqi Wang, Yuewen Gong, Judy Anderson, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|April 17, 2008
The use of budesonide in the treatment of autoimmune hepatitis in CanadaIman Zandieh, Darin Krygier, Victor Wong, et al.
Yonsei Medical Journal|April 4, 2015
IL28B is associated with outcomes of chronic HBV infectionXiaodong Shi, Xiumei Chi, Yu Pan, et al.
NMR in Biomedicine|August 19, 2014
In vivo 1H MRS of human gallbladder bile at 3 T in one and two dimensions: detection and quantification of major biliary lipidsSanaz Mohajeri, Omkar B Ijare, Tedros Bezabeh, et al.
NMR in Biomedicine|February 9, 2019
In vivo <sup>1</sup> H MRS of human gallbladder bile in understanding the pathophysiology of primary sclerosing cholangitis (PSC): Immune-mediated disease versus bile acid-induced injurySanaz Mohajeri, Tedros Bezabeh, Omkar B Ijare, et al.
The American Journal of Gastroenterology|July 6, 2004
Efficacy and safety of two-dose regimens of peginterferon alpha-2a compared with interferon alpha-2a in chronic hepatitis C: a multicenter, randomized controlled trialPaul J Pockros, Robert Carithers, Paul Desmond, et al.
Alaska Medicine|October 13, 2007
Viral hepatitis in the Arctic. A review from a Circumpolar Workshop on Viral hepatitis, ICCH13Andrei Tulisov, Brian J McMahon, Anders Koch, et al.
Hepatology Communications|March 8, 2021
Efficacy and Safety of Cenicriviroc in Patients With Primary Sclerosing Cholangitis: PERSEUS StudyBertus Eksteen, Christopher L Bowlus, Aldo J Montano-Loza, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Canadian Liver Journal|December 28, 2023
Comparison of different definitions of metabolic syndrome and their associations with non-alcoholic fatty liver disease: a retrospective studyCarmen Tse, Nicholas Lisanti, Micah Grubert Van Iderstine, et al.
Canadian Liver Journal|August 22, 2022
Circulating and inducible IL-32α in chronic hepatitis C virus infectionMark Collister, Julia Rempel, Jiaqi Yang, et al.
Hepatology (Baltimore, Md.)|September 22, 2005
Antioxidative function of L-FABP in L-FABP stably transfected Chang liver cellsGuqi Wang, Yuewen Gong, Judy Anderson, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|April 17, 2008
The use of budesonide in the treatment of autoimmune hepatitis in CanadaIman Zandieh, Darin Krygier, Victor Wong, et al.
Yonsei Medical Journal|April 4, 2015
IL28B is associated with outcomes of chronic HBV infectionXiaodong Shi, Xiumei Chi, Yu Pan, et al.
NMR in Biomedicine|August 19, 2014
In vivo 1H MRS of human gallbladder bile at 3 T in one and two dimensions: detection and quantification of major biliary lipidsSanaz Mohajeri, Omkar B Ijare, Tedros Bezabeh, et al.
NMR in Biomedicine|February 9, 2019
In vivo <sup>1</sup> H MRS of human gallbladder bile in understanding the pathophysiology of primary sclerosing cholangitis (PSC): Immune-mediated disease versus bile acid-induced injurySanaz Mohajeri, Tedros Bezabeh, Omkar B Ijare, et al.
The American Journal of Gastroenterology|July 6, 2004
Efficacy and safety of two-dose regimens of peginterferon alpha-2a compared with interferon alpha-2a in chronic hepatitis C: a multicenter, randomized controlled trialPaul J Pockros, Robert Carithers, Paul Desmond, et al.
Alaska Medicine|October 13, 2007
Viral hepatitis in the Arctic. A review from a Circumpolar Workshop on Viral hepatitis, ICCH13Andrei Tulisov, Brian J McMahon, Anders Koch, et al.
Hepatology Communications|March 8, 2021
Efficacy and Safety of Cenicriviroc in Patients With Primary Sclerosing Cholangitis: PERSEUS StudyBertus Eksteen, Christopher L Bowlus, Aldo J Montano-Loza, et al.
Pageof 3